Inovio Pharmaceuticals, Inc. (INO) vs Tiziana Life Sciences Ltd (TLSA)

Inovio Pharmaceuticals, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Tiziana Life Sciences Ltd are of similar size ($131.1M and $126.9M). Across the 8 metrics below, Tiziana Life Sciences Ltd leads on 5 and Inovio Pharmaceuticals, Inc. on 3.

Valuation

Metric INO TLSA Biotechnology median
P/E n/m n/m 7.88
P/S 249.64 n/m 11.47
P/B 22.03 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.04 0.74
EV/Sales 183.59 n/m 10.73
Earnings yield (77.12%) (51.86%) (28.84%)
Free cash flow yield (83.14%) 0.00% (23.03%)

Profitability

Metric INO TLSA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) 0.00% (57.72%)
Return on assets (114.64%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO TLSA Biotechnology median
Revenue growth (TTM) (54.82%) — 5.64%
EPS growth (last fiscal year) 54.18% (45.45%) —
Revenue growth, 5-year CAGR (61.18%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 0.76 4.73
Net debt to EBITDA 0.70 0.19 0.96

Dividend

Metric INO TLSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INO TLSA Biotechnology median
Market cap 126.89m 131.11m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack